Cargando…

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial

INTRODUCTION: Chemotherapy-induced polyneuropathy (CIPN) and post-chemotherapy cognitive impairment (PCCI) are frequent side effects of paclitaxel treatment. CIPN/PCCI are potentially irreversible, reduce quality of life and often lead to treatment limitations, which affect patients’ outcome. We pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huehnchen, Petra, Bangemann, Nikola, Lischewski, Sandra, Märschenz, Stefanie, Paul, Friedemann, Schmitz-Hübsch, Tanja, Blohmer, Jens-Uwe, Eberhardt, Cornelia, Rauch, Geraldine, Flöel, Agnes, Adam, Sophie, Schwenkenbecher, Philipp, Meinhold-Heerlein, Ivo, Hoffmann, Oliver, Ziemssen, Tjalf, Endres, Matthias, Boehmerle, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403739/ https://www.ncbi.nlm.nih.gov/pubmed/36035422 http://dx.doi.org/10.3389/fmed.2022.967964

Ejemplares similares

Assessment of Paclitaxel Induced Sensory Polyneuropathy with “Catwalk” Automated Gait Analysis in Mice
por: Huehnchen, Petra, et al.
Publicado: (2013)

Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice
por: Huehnchen, Petra, et al.
Publicado: (2020)

Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice
por: Boehmerle, Wolfgang, et al.
Publicado: (2014)

A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice
por: Huehnchen, P, et al.
Publicado: (2017)

Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy
por: Huehnchen, Petra, et al.
Publicado: (2018)

Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy
por: Huehnchen, Petra, et al.
Publicado: (2022)

Focal brain ischemia in mice does not cause electrophysiological signs of critical illness neuropathy
por: Huehnchen, Petra, et al.
Publicado: (2020)

Induced pluripotent stem cell-derived brain organoids as potential human model system for chemotherapy induced CNS toxicity
por: Scholz, Sophie, et al.
Publicado: (2022)

Suramin-Induced Neurotoxicity: Preclinical Models and Neuroprotective Strategies
por: von der Ahe, David, et al.
Publicado: (2018)

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

Bortezomib at therapeutic doses poorly passes the blood–brain barrier and does not impair cognition
por: Huehnchen, Petra, et al.
Publicado: (2020)

Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Dataset for: Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons
por: Schinke, Christian, et al.
Publicado: (2021)

Salinomycin induces calpain and cytochrome c-mediated neuronal cell death
por: Boehmerle, W, et al.
Publicado: (2011)

On the Reliability of Examining Dual-Tasking Abilities Using a Novel E-Health Device—A Proof of Concept Study in Multiple Sclerosis
por: Böttrich, Niels, et al.
Publicado: (2020)

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)
por: Ziemssen, Tjalf, et al.
Publicado: (2022)

Endometriosis: A concise practical guide to current diagnosis and treatment
por: Alkatout, İbrahim, et al.
Publicado: (2018)

Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC)
por: Ziemssen, Tjalf, et al.
Publicado: (2023)

Rationale of the PAPAartis trial
por: Misfeld, Martin, et al.
Publicado: (2023)

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Endometrial Carcinoma Presenting as Vasculitic Sensorimotor Polyneuropathy
por: Vasku, Marketa, et al.
Publicado: (2011)

Prevention of Intraoperative Hypothermia in Laparoscopy by the Use of Body-Temperature and Humidified CO (2) : a Pilot Study
por: Wittenborn, Julia, et al.
Publicado: (2019)

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System—A Review
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

Why Cognitive–Cognitive Dual-Task Testing Assessment Should Be Implemented in Studies on Multiple Sclerosis and in Regular Clinical Practice
por: Beste, Christian, et al.
Publicado: (2020)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events
por: Müller-Jensen, Leonie, et al.
Publicado: (2023)

Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy — non-mitotic mechanisms of paclitaxel
por: Smith, Elizabeth R., et al.
Publicado: (2022)

Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): Safety analyses of a randomized clinical trial
por: Rackoll, Torsten, et al.
Publicado: (2021)

Deep Infiltrating Endometriosis: Diagnostic Accuracy of Preoperative Magnetic Resonance Imaging with Respect to Morphological Criteria
por: Harth, Sebastian, et al.
Publicado: (2023)

The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial
por: Schwarz, Claudia, et al.
Publicado: (2022)

The Alliance AMBUSH Trial: Rationale and Design
por: Mahajan, Anita, et al.
Publicado: (2022)

Homeopathy for seasonal allergic rhinitis: rationale, design and methods of the three-armed randomized controlled HOMEOSAR trial
por: Siewert, J., et al.
Publicado: (2022)

Size Does Not Make the Difference: 3D/4D Transperineal Sonographic Measurements of the Female Urethra in the Assessment of Urinary Incontinence Subtypes
por: Kupec, Tomas, et al.
Publicado: (2016)

Interdisziplinäre Kommunikation: Augenarztbriefe an diabetologische Schwerpunktpraxen (DSP)
por: Stock, Lydia, et al.
Publicado: (2020)

The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Fatigue and Sleep in Multiple Sclerosis Patients: A Comparison of Self-Report and Performance-Based Measures
por: Paucke, Madlen, et al.
Publicado: (2018)

The importance of collecting structured clinical information on multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hpng870d94vav4elslmd146hl8